R.H. Bluestein & Co’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $252K | Sell |
1,025
-175
| -15% | -$43K | 0.02% | 274 |
|
|
2022
Q2 | $297K | Hold |
1,200
| – | – | 0.02% | 248 |
|
|
2022
Q1 | $397K | Buy |
1,200
+200
| +20% | +$66.2K | 0.02% | 238 |
|
|
2021
Q4 | $359K | Hold |
1,000
| – | – | 0.01% | 278 |
|
|
2021
Q3 | $326K | Hold |
1,000
| – | – | 0.01% | 301 |
|
|
2021
Q2 | $312K | Hold |
1,000
| – | – | 0.01% | 320 |
|
|
2021
Q1 | $319K | Hold |
1,000
| – | – | 0.01% | 295 |
|
|
2020
Q4 | $324K | Sell |
1,000
-300
| -23% | -$97.2K | 0.01% | 265 |
|
|
2020
Q3 | $360K | Hold |
1,300
| – | – | 0.02% | 207 |
|
|
2020
Q2 | $314K | Buy |
+1,300
| New | +$314K | 0.02% | 226 |
|
|
2020
Q1 | – | Sell |
-3,325
| Closed | -$567K | – | 366 |
|
|
2019
Q4 | $567K | Buy |
3,325
+425
| +15% | +$72.5K | 0.03% | 141 |
|
|
2019
Q3 | $516K | Buy |
2,900
+1,575
| +119% | +$280K | 0.03% | 148 |
|
|
2019
Q2 | $345K | Sell |
1,325
-437
| -25% | -$114K | 0.02% | 207 |
|
|
2019
Q1 | $503K | Sell |
1,762
-1,200
| -41% | -$343K | 0.03% | 136 |
|
|
2018
Q4 | $963K | Sell |
2,962
-816
| -22% | -$265K | 0.08% | 54 |
|
|
2018
Q3 | $1.7M | Sell |
3,778
-3,042
| -45% | -$1.37M | 0.08% | 56 |
|
|
2018
Q2 | $2.79M | Sell |
6,820
-11,575
| -63% | -$4.74M | 0.14% | 46 |
|
|
2018
Q1 | $5.35M | Buy |
18,395
+13,995
| +318% | +$4.07M | 0.29% | 47 |
|
|
2017
Q4 | $825K | Sell |
4,400
-19,200
| -81% | -$3.6M | 0.04% | 96 |
|
|
2017
Q3 | $3.98M | Buy |
23,600
+20,750
| +728% | +$3.5M | 0.22% | 51 |
|
|
2017
Q2 | $408K | Buy |
2,850
+200
| +8% | +$28.6K | 0.02% | 167 |
|
|
2017
Q1 | $332K | Buy |
+2,650
| New | +$332K | 0.02% | 221 |
|